{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:07:32Z","timestamp":1792516052171,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/nsmb.3267","type":"journal-article","created":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T13:14:29Z","timestamp":1470057269000},"page":"811-820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":175,"title":["Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV"],"prefix":"10.1038","volume":"23","author":[{"given":"M Gordon","family":"Joyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo-Yu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaksandr","family":"Druz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Pui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ting","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J","family":"Rundlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Tsybovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivelin S","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos","family":"Guttman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Pancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallika","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinque","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume B E","family":"Stewart-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G","family":"Van Galen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Baxa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney S","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"BFnsmb3267_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","volume":"360","author":"CB Hall","year":"2009","unstructured":"Hall, C.B. et al. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360, 588\u2013598 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnsmb3267_CR2","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","volume":"282","author":"DK Shay","year":"1999","unstructured":"Shay, D.K. et al. Bronchiolitis-associated hospitalizations among US children, 1980\u20131996. J. Am. Med. Assoc. 282, 1440\u20131446 (1999).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnsmb3267_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jama.289.2.179","volume":"289","author":"WW Thompson","year":"2003","unstructured":"Thompson, W.W. et al. Mortality associated with influenza and respiratory syncytial virus in the United States. J. Am. Med. Assoc. 289, 179\u2013186 (2003).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnsmb3267_CR4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","volume":"375","author":"H Nair","year":"2010","unstructured":"Nair, H. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375, 1545\u20131555 (2010).","journal-title":"Lancet"},{"key":"BFnsmb3267_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","volume":"87","author":"JP van den Berg","year":"2011","unstructured":"van den Berg, J.P., Westerbeek, E.A., van der Klis, F.R., Berbers, G.A. & van Elburg, R.M. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum. Dev. 87, 67\u201372 (2011).","journal-title":"Early Hum. Dev."},{"key":"BFnsmb3267_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(67)91369-4","volume":"1","author":"JR Hobbs","year":"1967","unstructured":"Hobbs, J.R. & Davis, J.A. Serum gamma-G-globulin levels and gestational age in premature babies. Lancet 1, 757\u2013759 (1967).","journal-title":"Lancet"},{"key":"BFnsmb3267_CR7","doi-asserted-by":"publisher","first-page":"c1626","DOI":"10.1136\/bmj.c1626","volume":"340","author":"E Leuridan","year":"2010","unstructured":"Leuridan, E. et al. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. Br. Med. J. 340, c1626 (2010).","journal-title":"Br. Med. J."},{"key":"BFnsmb3267_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00919271","volume":"13","author":"H Sarvas","year":"1993","unstructured":"Sarvas, H., Sepp\u00e4l\u00e4, I., Kurikka, S., Siegberg, R. & M\u00e4kel\u00e4, O. Half-life of the maternal IgG1 allotype in infants. J. Clin. Immunol. 13, 145\u2013151 (1993).","journal-title":"J. Clin. Immunol."},{"key":"BFnsmb3267_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1086\/319690","volume":"183","author":"MS Lee","year":"2001","unstructured":"Lee, M.S. et al. Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants. J. Infect. Dis. 183, 1281\u20131284 (2001).","journal-title":"J. Infect. Dis."},{"key":"BFnsmb3267_CR10","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2013-0303","volume":"132","author":"CB Hall","year":"2013","unstructured":"Hall, C.B. et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics 132, e341\u2013e348 (2013).","journal-title":"Pediatrics"},{"key":"BFnsmb3267_CR11","unstructured":"Palivizumab: new indication. Moderate reduction in hospitalisation rate. Prescrire Int. 13, 213\u2013216 (2004)."},{"key":"BFnsmb3267_CR12","doi-asserted-by":"crossref","unstructured":"The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531\u2013537 (1998).","DOI":"10.1542\/peds.102.3.531"},{"key":"BFnsmb3267_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/infdis\/jiv406","volume":"213","author":"GM Glenn","year":"2016","unstructured":"Glenn, G.M. et al. A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age. J. Infect. Dis. 213, 411\u2013422 (2016).","journal-title":"J. Infect. Dis."},{"key":"BFnsmb3267_CR14","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1073\/pnas.1106536108","volume":"108","author":"KA Swanson","year":"2011","unstructured":"Swanson, K.A. et al. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc. Natl. Acad. Sci. USA 108, 9619\u20139624 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3267_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.vaccine.2015.05.093","volume":"34","author":"K Modjarrad","year":"2016","unstructured":"Modjarrad, K. et al. WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization Meeting held on 23-24 March 2015. Vaccine 34, 190\u2013197 (2016).","journal-title":"Vaccine"},{"key":"BFnsmb3267_CR16","first-page":"259","volume":"372","author":"RA Karron","year":"2013","unstructured":"Karron, R.A., Buchholz, U.J. & Collins, P.L. Live-attenuated respiratory syncytial virus vaccines. Curr. Top. Microbiol. Immunol. 372, 259\u2013284 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnsmb3267_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.coi.2015.04.005","volume":"35","author":"BS Graham","year":"2015","unstructured":"Graham, B.S., Modjarrad, K. & McLellan, J.S. Novel antigens for RSV vaccines. Curr. Opin. Immunol. 35, 30\u201338 (2015).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnsmb3267_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10156-002-0178-6","volume":"8","author":"P Pollack","year":"2002","unstructured":"Pollack, P. & Groothuis, J.R. Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV. J. Infect. Chemother. 8, 201\u2013206 (2002).","journal-title":"J. Infect. Chemother."},{"issue":"Suppl. B","key":"BFnsmb3267_CR19","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1053\/rmed.2002.1298","volume":"96","author":"J Young","year":"2002","unstructured":"Young, J. Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants. Respir. Med. 96 (Suppl. B), S31\u2013S35 (2002).","journal-title":"Respir. Med."},{"key":"BFnsmb3267_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1086\/514115","volume":"176","author":"S Johnson","year":"1997","unstructured":"Johnson, S. et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J. Infect. Dis. 176, 1215\u20131224 (1997).","journal-title":"J. Infect. Dis."},{"key":"BFnsmb3267_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrm1076","volume":"4","author":"PM Colman","year":"2003","unstructured":"Colman, P.M. & Lawrence, M.C. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell Biol. 4, 309\u2013319 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnsmb3267_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0168-1702(00)00149-0","volume":"68","author":"G Bolt","year":"2000","unstructured":"Bolt, G., Pedersen, L.\u00d8. & Birkeslund, H.H. Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. Virus Res. 68, 25\u201333 (2000).","journal-title":"Virus Res."},{"key":"BFnsmb3267_CR23","doi-asserted-by":"publisher","first-page":"11133","DOI":"10.1073\/pnas.1309070110","volume":"110","author":"L Liljeroos","year":"2013","unstructured":"Liljeroos, L., Krzyzaniak, M.A., Helenius, A. & Butcher, S.J. Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc. Natl. Acad. Sci. USA 110, 11133\u201311138 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3267_CR24","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1128\/JVI.00555-11","volume":"85","author":"JS McLellan","year":"2011","unstructured":"McLellan, J.S., Yang, Y., Graham, B.S. & Kwong, P.D. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J. Virol. 85, 7788\u20137796 (2011).","journal-title":"J. Virol."},{"key":"BFnsmb3267_CR25","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1073\/pnas.1115941109","volume":"109","author":"M Magro","year":"2012","unstructured":"Magro, M. et al. Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention. Proc. Natl. Acad. Sci. USA 109, 3089\u20133094 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3267_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature12442","volume":"501","author":"D Corti","year":"2013","unstructured":"Corti, D. et al. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature 501, 439\u2013443 (2013).","journal-title":"Nature"},{"key":"BFnsmb3267_CR27","doi-asserted-by":"publisher","first-page":"e1005035","DOI":"10.1371\/journal.ppat.1005035","volume":"11","author":"MS Gilman","year":"2015","unstructured":"Gilman, M.S. et al. Characterization of a prefusion-specific antibody that recognizes a quaternary, cleavage-dependent epitope on the RSV fusion glycoprotein. PLoS Pathog. 11, e1005035 (2015).","journal-title":"PLoS Pathog."},{"key":"BFnsmb3267_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nm.2071","volume":"16","author":"MJ Kwakkenbos","year":"2010","unstructured":"Kwakkenbos, M.J. et al. Generation of stable monoclonal antibody\u2013producing B cell receptor\u2013positive human memory B cells by genetic programming. Nat. Med. 16, 123\u2013128 (2010).","journal-title":"Nat. Med."},{"key":"BFnsmb3267_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.1234914","volume":"340","author":"JS McLellan","year":"2013","unstructured":"McLellan, J.S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113\u20131117 (2013).","journal-title":"Science"},{"key":"BFnsmb3267_CR30","doi-asserted-by":"publisher","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","volume":"7","author":"JO Ngwuta","year":"2015","unstructured":"Ngwuta, J.O. et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci. Transl. Med. 7, 309ra162 (2015).","journal-title":"Sci. Transl. Med."},{"key":"BFnsmb3267_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J.S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"BFnsmb3267_CR32","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.1038\/ncomms9143","volume":"6","author":"A Krarup","year":"2015","unstructured":"Krarup, A. et al. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat. Commun. 6, 8143 (2015).","journal-title":"Nat. Commun."},{"key":"BFnsmb3267_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/modpathol.3800725","volume":"20","author":"JE Johnson","year":"2007","unstructured":"Johnson, J.E., Gonzales, R.A., Olson, S.J., Wright, P.F. & Graham, B.S. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20, 108\u2013119 (2007).","journal-title":"Mod. Pathol."},{"key":"BFnsmb3267_CR34","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1016\/j.vaccine.2009.07.038","volume":"27","author":"JM Langley","year":"2009","unstructured":"Langley, J.M. et al. A dose-ranging study of a subunit respiratory syncytial virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults 65 years of age. Vaccine 27, 5913\u20135919 (2009).","journal-title":"Vaccine"},{"key":"BFnsmb3267_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/00006454-199409000-00008","volume":"13","author":"PR Paradiso","year":"1994","unstructured":"Paradiso, P.R. et al. Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old. Pediatr. Infect. Dis. J. 13, 792\u2013798 (1994).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnsmb3267_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0264-410X(94)90316-6","volume":"12","author":"DA Tristram","year":"1994","unstructured":"Tristram, D.A., Welliver, R.C., Hogerman, D.A., Hildreth, S.W. & Paradiso, P. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement. Vaccine 12, 551\u2013556 (1994).","journal-title":"Vaccine"},{"key":"BFnsmb3267_CR37","first-page":"1442","volume":"342","author":"J Cohen","year":"2013","unstructured":"Cohen, J. 2013 runners-up: in vaccine design, looks do matter. Science 342, 1442\u20131443 (2013).","journal-title":"Science"},{"key":"BFnsmb3267_CR38","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1128\/JVI.03451-14","volume":"89","author":"IS Georgiev","year":"2015","unstructured":"Georgiev, I.S. et al. Single-chain soluble BG505.SOSIP gp140 trimers as structural and antigenic mimics of mature closed HIV-1 Env. J. Virol. 89, 5318\u20135329 (2015).","journal-title":"J. Virol."},{"key":"BFnsmb3267_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.celrep.2015.03.047","volume":"11","author":"SK Sharma","year":"2015","unstructured":"Sharma, S.K. et al. Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design. Cell Rep. 11, 539\u2013550 (2015).","journal-title":"Cell Rep."},{"key":"BFnsmb3267_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/viro.2002.1497","volume":"298","author":"M Bego\u00f1a Ruiz-Arg\u00fcello","year":"2002","unstructured":"Bego\u00f1a Ruiz-Arg\u00fcello, M. et al. Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. Virology 298, 317\u2013326 (2002).","journal-title":"Virology"},{"key":"BFnsmb3267_CR41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3181\/00379727-112-28221","volume":"112","author":"HV Coates","year":"1963","unstructured":"Coates, H.V., Kendrick, L. & Chanock, R.M. Antigenic differences between two strains of respiratory syncytial virus. Proc. Soc. Exp. Biol. Med. 112, 958\u2013964 (1963).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BFnsmb3267_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/S0033583507004635","volume":"40","author":"CD Putnam","year":"2007","unstructured":"Putnam, C.D., Hammel, M., Hura, G.L. & Tainer, J.A. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q. Rev. Biophys. 40, 191\u2013285 (2007).","journal-title":"Q. Rev. Biophys."},{"key":"BFnsmb3267_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/bip.21638","volume":"95","author":"RP Rambo","year":"2011","unstructured":"Rambo, R.P. & Tainer, J.A. Characterizing flexible and intrinsically unstructured biological macromolecules by SAS using the Porod-Debye law. Biopolymers 95, 559\u2013571 (2011).","journal-title":"Biopolymers"},{"key":"BFnsmb3267_CR44","doi-asserted-by":"publisher","first-page":"9499","DOI":"10.1128\/JVI.01373-15","volume":"89","author":"B Liang","year":"2015","unstructured":"Liang, B. et al. Enhanced neutralizing antibody response induced by respiratory syncytial virus prefusion F protein expressed by a vaccine candidate. J. Virol. 89, 9499\u20139510 (2015).","journal-title":"J. Virol."},{"key":"BFnsmb3267_CR45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0092-8674(92)90140-8","volume":"68","author":"L Godley","year":"1992","unstructured":"Godley, L. et al. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell 68, 635\u2013645 (1992).","journal-title":"Cell"},{"key":"BFnsmb3267_CR46","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nsmb.3051","volume":"22","author":"YD Kwon","year":"2015","unstructured":"Kwon, Y.D. et al. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat. Struct. Mol. Biol. 22, 522\u2013531 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3267_CR47","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1073\/pnas.1523303113","volume":"113","author":"JJ Wong","year":"2016","unstructured":"Wong, J.J., Paterson, R.G., Lamb, R.A. & Jardetzky, T.S. Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form. Proc. Natl. Acad. Sci. USA 113, 1056\u20131061 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3267_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nsmb.2250","volume":"19","author":"X Wen","year":"2012","unstructured":"Wen, X. et al. Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat. Struct. Mol. Biol. 19, 461\u2013463 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3267_CR49","doi-asserted-by":"publisher","first-page":"16672","DOI":"10.1073\/pnas.1213802109","volume":"109","author":"BD Welch","year":"2012","unstructured":"Welch, B.D. et al. Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc. Natl. Acad. Sci. USA 109, 16672\u201316677 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnsmb3267_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.1177637","volume":"326","author":"GJ Nabel","year":"2009","unstructured":"Nabel, G.J. Philosophy of science: the coordinates of truth. Science 326, 53\u201354 (2009).","journal-title":"Science"},{"key":"BFnsmb3267_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s001090000084","volume":"78","author":"G Klebe","year":"2000","unstructured":"Klebe, G. Recent developments in structure-based drug design. J. Mol. Med. (Berl.) 78, 269\u2013281 (2000).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnsmb3267_CR52","doi-asserted-by":"publisher","first-page":"e55701","DOI":"10.1371\/journal.pone.0055701","volume":"8","author":"M Pancera","year":"2013","unstructured":"Pancera, M. et al. N332-directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function. PLoS One 8, e55701 (2013).","journal-title":"PLoS One"},{"key":"BFnsmb3267_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nsmb.1723","volume":"17","author":"JS McLellan","year":"2010","unstructured":"McLellan, J.S. et al. Structural basis of respiratory syncytial virus neutralization by motavizumab. Nat. Struct. Mol. Biol. 17, 248\u2013250 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnsmb3267_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jsb.2006.06.006","volume":"157","author":"JB Heymann","year":"2007","unstructured":"Heymann, J.B. & Belnap, D.M. Bsoft: image processing and molecular modeling for electron microscopy. J. Struct. Biol. 157, 3\u201318 (2007).","journal-title":"J. Struct. Biol."},{"key":"BFnsmb3267_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/jsbi.1999.4174","volume":"128","author":"SJ Ludtke","year":"1999","unstructured":"Ludtke, S.J., Baldwin, P.R. & Chiu, W. EMAN: semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128, 82\u201397 (1999).","journal-title":"J. Struct. Biol."},{"key":"BFnsmb3267_CR56","doi-asserted-by":"publisher","first-page":"e0128779","DOI":"10.1371\/journal.pone.0128779","volume":"10","author":"GB Stewart-Jones","year":"2015","unstructured":"Stewart-Jones, G.B. et al. A cysteine zipper stabilizes a pre-fusion F glycoprotein vaccine for respiratory syncytial virus. PLoS One 10, e0128779 (2015).","journal-title":"PLoS One"},{"key":"BFnsmb3267_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jmv.1890260207","volume":"26","author":"BS Graham","year":"1988","unstructured":"Graham, B.S., Perkins, M.D., Wright, P.F. & Karzon, D.T. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26, 153\u2013162 (1988).","journal-title":"J. Med. Virol."},{"key":"BFnsmb3267_CR58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.virol.2012.09.022","volume":"434","author":"AL Hotard","year":"2012","unstructured":"Hotard, A.L. et al. A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology 434, 129\u2013136 (2012).","journal-title":"Virology"},{"key":"BFnsmb3267_CR59","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0969-2126(03)00185-0","volume":"11","author":"S Majeed","year":"2003","unstructured":"Majeed, S. et al. Enhancing protein crystallization through precipitant synergy. Structure 11, 1061\u20131070 (2003).","journal-title":"Structure"},{"key":"BFnsmb3267_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"BFnsmb3267_CR61","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A.J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"BFnsmb3267_CR62","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W.G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnsmb3267_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P.D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnsmb3267_CR64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.str.2013.02.004","volume":"21","author":"M Guttman","year":"2013","unstructured":"Guttman, M., Weinkam, P., Sali, A. & Lee, K.K. All-atom ensemble modeling to analyze small-angle x-ray scattering of glycosylated proteins. Structure 21, 321\u2013331 (2013).","journal-title":"Structure"}],"container-title":["Nature Structural & Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nsmb.3267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nsmb.3267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nsmb.3267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:40:21Z","timestamp":1684456821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nsmb.3267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFnsmb3267"],"URL":"https:\/\/doi.org\/10.1038\/nsmb.3267","relation":{},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,1]]},"assertion":[{"value":"27 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The NIH has filed patents USPTO 20160046675 and USPTO 20140271699 on the use of prefusion-stabilized RSV F glycoproteins.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}